Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effectiveness and safety of cNEP (continuous negative external pressure) for the treatment of obstructive sleep apnea during two weeks of home use in subjects of Japanese ethnicity.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| cNEP | Experimental | cNEP treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cNEP | Device | subjects with OSA will be treated with the cNEP device with the goal of reducing the number of apneas and hypopneas |
|
| Measure | Description | Time Frame |
|---|---|---|
| proportion of sustained responders | reduction of AHI of >50% and to <15/hr from qualifying PSG | two weeks after initiation of treatment |
| Measure | Description | Time Frame |
|---|---|---|
| proportion of initial responders | reduction of AHI of >50% and to <15/hr from qualifying PSG | at PSG 1, one day |
| AHI comparison with qualifying PSG | apnea-hypopnea index |
Not provided
Inclusion Criteria:
Key exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jamil S Sulieman, MD | The Sleep Lab, Kaneohe, HI | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Sleep Lab | Kaneohe | Hawaii | 96744 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020181 | Sleep Apnea, Obstructive |
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| one day, on three separate study occasions |
| ODI comparison with qualifying PSG | oxygen desaturation index | one day, on three separate study occasions |
| SpO2 <90% comparison with qualifying PSG | oxygen desaturation index <90% | one day, on three separate study occasions |
| CGI of sleep | clinical global impressions of sleep, comparing 3-month baseline with end of two weeks of treatment | three months, and two weeks, respectively |
| CGI of satisfaction with the cNEP device | clinical global impressions of the cNEP device | after two weeks of treatment |
| Treatment-emergent adverse events | tabulation of treatment-emergent adverse events | two weeks |
| D020919 |
| Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |